arrow_back Back to App

Increased funding for HIV, Hepatitis, STD, and Tuberculosis prevention programs.

This bill aims to significantly boost funding for public health programs focused on infectious disease prevention. It appropriates $2.165 billion for fiscal year 2026 to the National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention (CDC). These additional funds are dedicated exclusively to improving prevention, testing, and treatment access, directly enhancing community health security and quality of life.
Key points
Public Health Funding: Allocates $2.165 billion for fiscal year 2026 to the CDC center focused on infectious disease prevention.
Purpose of Funds: Money must be used exclusively for programs combating HIV, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis.
Additional Resources: This amount is supplementary to the regular budgets of the Department of Health and Human Services, representing a real increase in spending for these purposes.
Non-transferable: The funds cannot be transferred to other entities or used for purposes other than those specified for the National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_5126
Sponsor: Rep. Waters, Maxine [D-CA-43]
Process start date: 2025-09-04
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

HIV Prevention Now Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_5126.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-09-04.

What are the main provisions?

Key points include:

  • Public Health Funding: Allocates $2.165 billion for fiscal year 2026 to the CDC center focused on infectious disease prevention.
  • Purpose of Funds: Money must be used exclusively for programs combating HIV, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis.
  • Additional Resources: This amount is supplementary to the regular budgets of the Department of Health and Human Services, representing a real increase in spending for these purposes.
  • Non-transferable: The funds cannot be transferred to other entities or used for purposes other than those specified for the National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Waters, Maxine [D-CA-43].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Appropriations.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-31.

CATEGORIES

Health Public Investments